Old Web
English
Sign In
Acemap
>
authorDetail
>
Hideo Suzuki
Hideo Suzuki
Takeda Pharmaceutical Company
Biochemistry
Arachidonic acid
Chemistry
Inflammation
Biology
4
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A novel orally available delta-5 desaturase inhibitor prevents atherosclerotic lesions accompanied with changes of fatty acid composition and eicosanoid production in ApoE knockout mice
2019
Journal of Pharmacology and Experimental Therapeutics
Shuichi Takagahara
Hiromi Shinohara
Shigekazu Itokawa
Yoshinori Satomi
Ayumi Ando
Takeshi Yamamoto
Hideo Suzuki
Takuya Fujimoto
Kazuki Kubo
Shota Ikeda
Show All
Source
Cite
Save
Citations (3)
T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence Time
2016
ACS Medicinal Chemistry Letters
Ikuo Miyahisa
Hideo Suzuki
Atsushi Mizukami
Yukiya Tanaka
Midori Ono
Mark S. Hixon
Junji Matsui
Show All
Source
Cite
Save
Citations (8)
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.
2012
Bioorganic & Medicinal Chemistry Letters
Yoshito Terao
Hideo Suzuki
Masato Yoshikawa
Hiroaki Yashiro
Shiro Takekawa
Yasushi Fujitani
Kengo Okada
Yoshihisa Inoue
Yoshio Yamamoto
Hideyuki Nakagawa
Shuhei Yao
Tomohiro Kawamoto
Osamu Uchikawa
Show All
Source
Cite
Save
Citations (42)
1